Insulin Market 2020 in Depth Study Followed by Top Companies 2026 - PowerPoint PPT Presentation

About This Presentation
Title:

Insulin Market 2020 in Depth Study Followed by Top Companies 2026

Description:

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision. – PowerPoint PPT presentation

Number of Views:45

less

Transcript and Presenter's Notes

Title: Insulin Market 2020 in Depth Study Followed by Top Companies 2026


1
Insulin Market To Reach USD 35.74 Billion By 2027
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Increasing elderly populations, rising incidence
of obese-related diabetes, and favorable
reimbursement scenario are the key factors
leading to the burgeoning growth in
demand. Market Size USD 24.47 Billion in 2018,
Market Growth - CAGR of 4.2, Market Trends
Growing incidence of diabetes.
3
Our Approach
Market Summary
  • The global Insulin Market is forecast to reach
    USD 35.74 Billion by 2027, according to a new
    report by Reports and Data. Insulin therapy is
    used for the treatment of patients with all types
    of diabetes.
  • The need for insulin therapy depends upon the
    balance between insulin resistance and insulin
    secretion. Patients with type 1 diabetes require
    insulin treatment permanently unless they receive
    a whole organ pancreas transplant or an islet.
    Type 2 diabetes patients require insulin as their
    beta-cell function lowers over time.
  • Diabetes and its complications, societal costs,
    and deaths have a huge and rapidly growing impact
    across the globe. In 2019 approximate 463
    million adults (20-79 years) were living with
    diabetes and by 2045 this is expected to rise to
    700 million. A growing number of diabetic
    patients are propelling the demand for insulin.
  • The market in Asia Pacific is estimated to
    witness an increasing demand in the forecast
    period owing to growing awareness pertaining to
    medical treatments and care, rising health care
    sector, and an increase in RD activities.
    Further, a rapid increase in the diabetic
    population and increasing adoption of insulin
    administration are driving the market demand in
    the region.
  • Request for a sample of this research report _at_
    https//www.reportsanddata.com/sample-enquiry-form
    /2338

4
Our Approach
Market Summary
  • Further key findings from the report suggest
  • The reason healthcare providers prescribe care
    users medications that can be injected with the
    help of an insulin pen is, the patient can inject
    the medicine himself/herself. The ability of care
    users to take medicine on their own and
    incorporate it in-home healthcare results in
    enhanced care user's adherence to care regimes
    that improve their quality of life and minimizes
    healthcare costs.
  • An insulin pump is a delivery device that pushes
    small, steady doses of rapid-acting insulin into
    a thin tube and is inserted underneath the
    patient's skin. There are several different kinds
    of insulin pumps available. These dosages are
    delivered repeatedly throughout the day.
  • Biosimilar insulins are a biological copy of an
    original insulin, and there is an increasing
    interest in developing and using them. These
    insulins are cheaper than original products, so
    they present the NHS with opportunities around
    availability and cost of care. However, there is
    a lack of awareness among healthcare
    professionals and people with diabetes about
    their use.
  • To identify the key trends in the industry, click
    on the link below https//www.reportsanddata.com/
    report-detail/insulin-market

5
Our Approach
Market Summary
  • Key participants include Novo Nordisk A/S,
    Sanofi, Eli Lily and Company, ADOCIA, Julphar,
    Pfizer, Inc., Oramed Pharmaceuticals, Inc.,
    Bristol-Myers Squibb Company, Merck Co., Inc.,
    and GlaxoSmithKline Plc, among others.
  • For the purpose of this report, Reports and Data
    have segmented into the global Insulin Market on
    the basis of product type, diseases, delivery
    devices, end-users, and region
  • Product Type Outlook (Revenue, USD Billion
    2016-2027)
  • Basal or Long-Acting Insulin
  • Bolus or Fast-Acting Insulin
  • Traditional Human Insulin
  • Combination Insulin
  • Biosimilar Insulin
  • Diseases Outlook (Revenue, USD Billion
    2016-2027)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
  • Prediabetes

6
Our Approach
Market Summary
  • End-Users Outlook (Revenue, USD Billion
    2016-2027)
  • Home healthcare
  • Hospitals
  • Over the counter (OTC)
  • Clinics
  • Others
  • Order Now https//www.reportsanddata.com/checkout
    -form/2338

7
Our Approach
About Us
  • Reports and Data is a market research and
    consulting company that provides syndicated
    research reports, customized research reports,
    and consulting services. Our solutions purely
    focus on your purpose to locate, target and
    analyze consumer behavior shifts across
    demographics, across industries and help clients
    make a smarter business decision. We offer market
    intelligence studies ensuring relevant and
    fact-based research across a multiple industries
    including Healthcare, Technology, Chemicals,
    Power, and Energy. We consistently update our
    research offerings to ensure our clients are
    aware about the latest trends existent in the
    market. Reports and Data has a strong base of
    experienced analysts from varied areas of
    expertise.
  • Contact Us
  • John Watson
  • Head of Business Development
  • Reports And Data Web www.reportsanddata.com
  • Direct Line 1-212-710-1370
  • E-mail sales_at_reportsanddata.com
Write a Comment
User Comments (0)
About PowerShow.com